Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP
Clinical trial NCT00022932 · UNKNOWN
Trial details
- NCT number
- NCT00022932
- Sponsor
- Corixa Corporation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.